PUBLIC CONTRACT · 2025
ECULIZUMAB 300mg SOL INJ FR 30ml IV, para doente específico
- Contract value
- €160,251.00
- Signed on
- 26 March 2025
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11319084PUBLISHED SUBJECT
ECULIZUMAB 300mg SOL INJ FR 30ml IV, para doente específico
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Porto, Porto
- NUTS region
- PT11A - Área Metropolitana do Porto
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ALEXION PHARMA SPAIN S L - SUCURSAL PORTUGAL · Tax ID 980553768
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €160,251.00
- Procedure base price
- €160,251.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 31 March 2025
- Award date
- 13 March 2025
- Signing date
- 26 March 2025
- Performance period
- 306 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7500801
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.